JN
John Newman Canaccord Genuity Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Regeneron Pharmaceuticals
REGN
$59.2B
| $556.53 | $850 |
53%
upside
| Buy |
23 Jul ‘25
1 month ago |
|
2
Allogene Therapeutics
ALLO
$253M
| $1.14 | $14 |
1,128%
upside
| Buy |
14 Mar ‘25
5 months ago |
|
3
BioNTech
BNTX
$24.7B
| $102.09 | $171.44 |
68%
upside
| Buy |
11 Mar ‘25
6 months ago |
|
4
Atara Biotherapeutics
ATRA
$85.5M
| $11.95 | $17 |
42%
upside
| Buy |
11 Mar ‘25
6 months ago |
|
5
Marker Therapeutics
MRKR
$11.3M
| $0.8510 | $8 |
840%
upside
| Buy |
5 Mar ‘25
6 months ago |
|
6
Candel Therapeutics
CADL
$280M
| $4.97 | $25 |
403%
upside
| Buy |
26 Feb ‘25
6 months ago |
|
7
Seres Therapeutics
MCRB
$200M
| $18.64 | $200 |
973%
upside
| Buy |
14 Nov ‘24
9 months ago |
|
|
IRD
8
Opus Genetics, Inc. Common Stock
IRD
$83.9M
| $1.36 | $10 |
635%
upside
| Buy |
23 Oct ‘24
10 months ago |
|
9
Delcath Systems
DCTH
$404M
| $11.60 | $21 |
81%
upside
| Buy |
18 Oct ‘24
10 months ago |
|
10
Arcellx
ACLX
$3.94B
| $72.04 | $115 |
60%
upside
| Buy |
17 Oct ‘24
10 months ago |
|
11
Adicet Bio
ACET
$63.5M
| $0.8037 | $8 |
895%
upside
| Buy |
11 Sep ‘24
1 year ago |
|
12
Merus
MRUS
$5.08B
| $68.55 | $67 |
2%
downside
| Buy |
25 Jul ‘24
1 year ago |
|
13
Cartesian Therapeutics
RNAC
$265M
| $10.09 | $43 |
326%
upside
| Buy |
3 Jul ‘24
1 year ago |
|
|
ONCY
14
Oncolytics Biotech
ONCY
$130M
| $1.39 | $5 |
260%
upside
| Buy |
23 Jun ‘23
2 years ago |
|
15
Agios Pharmaceuticals
AGIO
$2.12B
| $36.15 | $44 |
22%
upside
| Buy |
16 Feb ‘22
3 years ago |
|
16
Carisma Therapeutics
CARM
$16.6M
| $0.4139 | $140 |
33,725%
upside
| Buy |
17 Feb ‘21
4 years ago |
|